Human mast cell-expressed membrane protein

Details for Australian Patent Application No. 2004259399 (hide)

Owner Tanox, Inc.

Inventors Wang, Shen-Wu; Yao, Zhengbin; Li, Kang; Hu, Guanghui

Agent Spruson & Ferguson

Pub. Number AU-A-2004259399

PCT Pub. Number WO2005/010152

Priority 60/483,360 27.06.03 US

Filing date 25 June 2004

Wipo publication date 3 February 2005

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/010152 Priority application(s): WO2005/010152

22 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259404-Eradicable gel ink, methods of eradication of the same, eradicable ink kit, and eradicated ink complex

2004259398-Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof